Journal of Antimicrobial Chemotherapy (1999) 43, 367-371
© 1999 The British Society for Antimicrobial Chemotherapy
Efficacy of ß-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice
Department of Microbiology, Toho University School of Medicine, 5-21-16 Ohmori-nishi, Ohta-ku, Tokyo 143, Japan
We examined the efficacy of gentamicin combined with ß-lactam antibiotics against penicillin-resistant Streptococcus pneumoniae (PRSP) in a noncompromised mouse model of pneumonia. In the presence of 8 mg/L (0.25 x MIC) and 16 mg/L (0.5 x MIC) of gentamicin, MICs of penicillin G against 23 strains of PRSP decreased from 1–4 mg/L to 0.03 mg/L in 14 (61%) and 23 strains (100%), respectively. A short-time killing study using strain 741 showed that 8 mg/L of gentamicin (0.25 x MIC) increased the killing activity of penicillin G, cefotaxime and imipenem (at 0.25, 1 and 4 x MIC) during a 6 h incubation period. Survival studies showed that the combined treatment of penicillin-G (160 mg/kg) and gentamicin (10 mg/kg), which commenced 2 days after infection (twice a day for 5 days), provided complete protection, while no animal survived when either antibiotic was used alone. A significant improvement in mortality was observed when a small dose of imipenem (2.5 and 10 mg/kg) was used with gentamicin. Our results suggest that gentamicin, when combined with ß-lactam antibiotics, especially imipenem, may be potentially useful against PRSP pneumonia in noncompromised individuals.
* Corresponding author. Tel:+81-3-3762-4151; Fax:+81-3-5493-5415; E-mail: kazu{at}med.tobo-u.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Chiavolini, G. Pozzi, and S. Ricci Animal Models of Streptococcus pneumoniae Disease Clin. Microbiol. Rev., October 1, 2008; 21(4): 666 - 685. [Abstract] [Full Text] [PDF]
|
|